These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 39543140)
1. MDM4 inhibits ferroptosis in p53 mutant colon cancer via regulating TRIM21/GPX4 expression. Liu J; Wei X; Xie Y; Yan Y; Xue S; Wang X; Chen H; Pan Q; Yan S; Zheng X; Huang Q Cell Death Dis; 2024 Nov; 15(11):825. PubMed ID: 39543140 [TBL] [Abstract][Full Text] [Related]
2. Augmented antitumor activity of 5-fluorouracil by double knockdown of MDM4 and MDM2 in colon and gastric cancer cells. Imanishi M; Yamamoto Y; Wang X; Sugaya A; Hirose M; Endo S; Natori Y; Yamato K; Hyodo I Cancer Sci; 2019 Feb; 110(2):639-649. PubMed ID: 30488540 [TBL] [Abstract][Full Text] [Related]
3. Luteolin exhibits synergistic therapeutic efficacy with erastin to induce ferroptosis in colon cancer cells through the HIC1-mediated inhibition of GPX4 expression. Zheng Y; Li L; Chen H; Zheng Y; Tan X; Zhang G; Jiang R; Yu H; Lin S; Wei Y; Wang Y; Zhang R; Liu Z; Wu J Free Radic Biol Med; 2023 Nov; 208():530-544. PubMed ID: 37717793 [TBL] [Abstract][Full Text] [Related]
4. Mdm2 Splice isoforms regulate the p53/Mdm2/Mdm4 regulatory circuit via RING domain-mediated ubiquitination of p53 and Mdm4. Fan C; Wang X Cell Cycle; 2017 Apr; 16(7):660-664. PubMed ID: 28166445 [TBL] [Abstract][Full Text] [Related]
5. CISD2 downregulation participates in the ferroptosis process of human ovarian SKOV-3 cells through modulating the wild type p53-mediated GLS2/SAT1/SLC7A11 and Gpx4/TRF signaling pathway. Wang Y; Yi Y Tissue Cell; 2024 Aug; 89():102458. PubMed ID: 38991271 [TBL] [Abstract][Full Text] [Related]
6. Targeting GPX4-mediated ferroptosis protection sensitizes BRCA1-deficient cancer cells to PARP inhibitors. Xie X; Chen C; Wang C; Guo Y; Sun B; Tian J; Yan J; Li D; Chen G Redox Biol; 2024 Oct; 76():103350. PubMed ID: 39265497 [TBL] [Abstract][Full Text] [Related]
7. Protein phosphatase 2A-B55β mediated mitochondrial p-GPX4 dephosphorylation promoted sorafenib-induced ferroptosis in hepatocellular carcinoma via regulating p53 retrograde signaling. Qian B; Che L; Du ZB; Guo NJ; Wu XM; Yang L; Zheng ZX; Gao YL; Wang MZ; Chen XX; Xu L; Zhou ZJ; Lin YC; Lin ZN Theranostics; 2023; 13(12):4288-4302. PubMed ID: 37554285 [No Abstract] [Full Text] [Related]
8. Triptolide induced spermatogenesis dysfunction via ferroptosis activation by promoting K63-linked GPX4 polyubiquitination in spermatocytes. Li J; Chen D; Suo J; Li J; Zhang Y; Wang Y; Deng Z; Zhang Q; Ma B Chem Biol Interact; 2024 Aug; 399():111130. PubMed ID: 38960301 [TBL] [Abstract][Full Text] [Related]
9. Longikaurin A induces ferroptosis and inhibits glioblastoma progression through DNA methylation - Mediated GPX4 suppression. Meng X; Yang Q; Gao Y; Liu Y; Chen F; Cao W; Sun G Eur J Pharmacol; 2024 Dec; 984():177061. PubMed ID: 39426467 [TBL] [Abstract][Full Text] [Related]
10. iPLA2β-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4. Chen D; Chu B; Yang X; Liu Z; Jin Y; Kon N; Rabadan R; Jiang X; Stockwell BR; Gu W Nat Commun; 2021 Jun; 12(1):3644. PubMed ID: 34131139 [TBL] [Abstract][Full Text] [Related]
11. Curcumin suppresses colorectal cancer by induction of ferroptosis via regulation of p53 and solute carrier family 7 member 11/glutathione/glutathione peroxidase 4 signaling axis. Ming T; Lei J; Peng Y; Wang M; Liang Y; Tang S; Tao Q; Wang M; Tang X; He Z; Liu X; Xu H Phytother Res; 2024 Aug; 38(8):3954-3972. PubMed ID: 38837315 [TBL] [Abstract][Full Text] [Related]
12. Intracellular C5aR1 inhibits ferroptosis in glioblastoma through METTL3-dependent m6A methylation of GPX4. Meng X; Wang Z; Yang Q; Liu Y; Gao Y; Chen H; Li A; Li R; Wang J; Sun G Cell Death Dis; 2024 Oct; 15(10):729. PubMed ID: 39368999 [TBL] [Abstract][Full Text] [Related]
13. MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma. Woodfield SE; Shi Y; Patel RH; Chen Z; Shah AP; Srivastava RK; Whitlock RS; Ibarra AM; Larson SR; Sarabia SF; Badachhape A; Starosolski Z; Ghaghada KB; Sumazin P; Annis DA; López-Terrada D; Vasudevan SA Sci Rep; 2021 Feb; 11(1):2967. PubMed ID: 33536467 [TBL] [Abstract][Full Text] [Related]
14. LACTB suppresses liver cancer progression through regulation of ferroptosis. Zeng K; Huang N; Liu N; Deng X; Mu Y; Zhang X; Zhang J; Zhang C; Li Y; Li Z Redox Biol; 2024 Sep; 75():103270. PubMed ID: 39047638 [TBL] [Abstract][Full Text] [Related]
15. Heterozygous p53(V172F) mutation in cisplatin-resistant human tumor cells promotes MDM4 recruitment and decreases stability and transactivity of p53. Xie X; Lozano G; Siddik ZH Oncogene; 2016 Sep; 35(36):4798-806. PubMed ID: 26876197 [TBL] [Abstract][Full Text] [Related]
16. miR‑205 suppresses cell migration, invasion and EMT of colon cancer by targeting mouse double minute 4. Fan Y; Wang K Mol Med Rep; 2020 Aug; 22(2):633-642. PubMed ID: 32467998 [TBL] [Abstract][Full Text] [Related]
17. MDM4 is a key therapeutic target in cutaneous melanoma. Gembarska A; Luciani F; Fedele C; Russell EA; Dewaele M; Villar S; Zwolinska A; Haupt S; de Lange J; Yip D; Goydos J; Haigh JJ; Haupt Y; Larue L; Jochemsen A; Shi H; Moriceau G; Lo RS; Ghanem G; Shackleton M; Bernal F; Marine JC Nat Med; 2012 Aug; 18(8):1239-47. PubMed ID: 22820643 [TBL] [Abstract][Full Text] [Related]
18. Mutual regulation of MDM4 and TOP2A in cancer cell proliferation. Liu T; Zhang H; Yi S; Gu L; Zhou M Mol Oncol; 2019 May; 13(5):1047-1058. PubMed ID: 30672125 [TBL] [Abstract][Full Text] [Related]
19. The E3 ligase TRIM26 suppresses ferroptosis through catalyzing K63-linked ubiquitination of GPX4 in glioma. Wang Z; Xia Y; Wang Y; Zhu R; Li H; Liu Y; Shen N Cell Death Dis; 2023 Oct; 14(10):695. PubMed ID: 37872147 [TBL] [Abstract][Full Text] [Related]
20. MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma. Hüllein J; Słabicki M; Rosolowski M; Jethwa A; Habringer S; Tomska K; Kurilov R; Lu J; Scheinost S; Wagener R; Huang Z; Lukas M; Yavorska O; Helfrich H; Scholtysik R; Bonneau K; Tedesco D; Küppers R; Klapper W; Pott C; Stilgenbauer S; Burkhardt B; Löffler M; Trümper LH; Hummel M; Brors B; Zapatka M; Siebert R; Kreuz M; Keller U; Huber W; Zenz T Cancer Res; 2019 Jun; 79(12):3125-3138. PubMed ID: 31000522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]